Search Results - "Horvatits, Thomas"

Refine Results
  1. 1

    Microplastics detected in cirrhotic liver tissue by Horvatits, Thomas, Tamminga, Matthias, Liu, Beibei, Sebode, Marcial, Carambia, Antonella, Fischer, Lutz, Püschel, Klaus, Huber, Samuel, Fischer, Elke Kerstin

    Published in EBioMedicine (01-08-2022)
    “…The contamination of ecosystem compartments by microplastics (MPs) is an ubiquitous problem. MPs have been observed in mice tissues, and recently in human…”
    Get full text
    Journal Article
  2. 2

    The Clinical Perspective on Hepatitis E by Horvatits, Thomas, Schulze Zur Wiesch, Julian, Lütgehetmann, Marc, Lohse, Ansgar W, Pischke, Sven

    Published in Viruses (05-07-2019)
    “…Every year, there are an estimated 20 million hepatitis E virus (HEV) infections worldwide, leading to an estimated 3.3 million symptomatic cases of hepatitis…”
    Get full text
    Journal Article
  3. 3

    Muscle quality determined by computed tomography predicts short-term and long-term survival after liver transplantation by Molwitz, Isabel, Recklies, Franziska, Stark, Maria, Horvatits, Thomas, Salamon, Johannes, Huber, Samuel, Fischer, Lutz, Adam, Gerhard, Lohse, Ansgar W., Sterneck, Martina, Horvatits, Karoline

    Published in Scientific reports (10-05-2023)
    “…Sarcopenia, the loss of muscle mass and quality, contributes to worse clinical outcome in patients with end-stage liver disease, but its impact on short- and…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Course of HEV viremia and anti-HEV IgM/IgG response in asymptomatic blood donors by Kraef, Christian, Schlein, Christian, Hiller, Jens, Westhölter, Dirk, Denzer, Ulrike, Horvatits, Thomas, Peine, Sven, Lohse, Ansgar W., Lütgehetmann, Marc, Polywka, Susanne, Pischke, Sven

    Published in Journal of clinical virology (01-08-2018)
    “…•We describe the time course and viral kinetics of HEV-RNA and anti-HEV IgM/IgG in blood donors.•The median time span for viral clearance was 55 days, three…”
    Get full text
    Journal Article
  6. 6

    Improvement of renal function prior to liver transplantation is not associated with better long-term renal outcome or survival by Horvatits, Thomas, Hübener, Peter, Touma, Marcel, Horvatits, Karoline, Fischer, Lutz, Lohse, Ansgar W., Sterneck, Martina

    Published in Annals of hepatology (01-12-2021)
    “…Since MELD implementation renal impairment in liver transplant (LT) recipients has become of increasing importance. This is the first study evaluating the…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10

    Higher Risk of HEV Transmission and Exposure among Blood Donors in Europe and Asia in Comparison to North America: A Meta-Analysis by Wolski, Annika, Pischke, Sven, Ozga, Ann-Kathrin, Addo, Marylyn M, Horvatits, Thomas

    Published in Pathogens (Basel) (01-03-2023)
    “…The increasing number of diagnosed hepatitis E virus (HEV) infections in Europe has led to the implementation of the testing of blood products in various…”
    Get full text
    Journal Article
  11. 11

    Circulating bile acids predict outcome in critically ill patients by Horvatits, Thomas, Drolz, Andreas, Rutter, Karoline, Roedl, Kevin, Langouche, Lies, Van den Berghe, Greet, Fauler, Günter, Meyer, Brigitte, Hülsmann, Martin, Heinz, Gottfried, Trauner, Michael, Fuhrmann, Valentin

    Published in Annals of intensive care (02-05-2017)
    “…Background Jaundice and cholestatic hepatic dysfunction are frequent findings in critically ill patients associated with increased mortality. Cholestasis in…”
    Get full text
    Journal Article
  12. 12

    Ascites control by TIPS is more successful in patients with a lower paracentesis frequency and is associated with improved survival by Piecha, Felix, Radunski, Ulf K, Ozga, Ann-Kathrin, Steins, David, Drolz, Andreas, Horvatits, Thomas, Spink, Clemens, Ittrich, Harald, Benten, Daniel, Lohse, Ansgar W, Sinning, Christoph, Kluwe, Johannes

    Published in JHEP reports (01-08-2019)
    “…Refractory ascites is the main reason for the implantation of a transjugular intrahepatic portosystemic shunt (TIPS) in liver cirrhosis, but ascites control by…”
    Get full text
    Journal Article
  13. 13

    Pharmacokinetics of Ganciclovir during Continuous Venovenous Hemodiafiltration in Critically Ill Patients by Horvatits, Thomas, Kitzberger, Reinhard, Drolz, Andreas, Zauner, Christian, Jäger, Walter, Böhmdorfer, Michaela, Kraff, Stefanie, Fritsch, Achim, Thalhammer, Florian, Fuhrmann, Valentin, Schenk, Peter

    Published in Antimicrobial Agents and Chemotherapy (01-01-2014)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Lower Levels of Transaminases but Higher Levels of Serum Creatinine in Patients with Acute Hepatitis E in Comparison to Patients with Hepatitis A by Brehm, Thomas Theo, Mazaheri, Omid, Horvatits, Thomas, Lütgehetmann, Marc, Schulze Zur Wiesch, Julian, Lohse, Ansgar W, Polywka, Susanne, Pischke, Sven

    Published in Pathogens (Basel) (12-01-2021)
    “…In patients with hepatitis E virus (HEV) infections, extrahepatic, particularly renal and hematological manifestations, are increasingly reported in the…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    HEV-Associated Neuralgic Amyotrophy: A Multicentric Case Series by Bannasch, Johannes H., Berger, Benjamin, Schwartkop, Claus-Peter, Berning, Marco, Goetze, Oliver, Panning, Marcus, Fritz-Weltin, Miriam, Trendelenburg, George, Gelderblom, Mathias, Lütgehetmann, Marc, Stute, Fridrike, Horvatits, Thomas, Dirks, Meike, Antoni, Christoph, Behrendt, Patrick, Pischke, Sven

    Published in Pathogens (Basel) (30-05-2021)
    “…Background: Neuralgic amyotrophy (NA) has been described as a possible extrahepatic manifestation of hepatitis E virus (HEV) infection. Usually, HEV-associated…”
    Get full text
    Journal Article
  20. 20